BIOMAT Database Logo BIOMAT Database Logo

Factors affecting seropositivity to human T cell lymphotropic virus type III (HTLV-III) or lymphadenopathy associated virus (LAV) and progression of disease in sexual partners of patients with AIDS. 1986

J N Weber, and A McCreaner, and E Berrie, and J Wadsworth, and D J Jeffries, and A J Pinching, and J R Harris

Fifty four sexual partners of homosexual men with the acquired immune deficiency syndrome (AIDS) were studied, of whom 32 were seropositive and 22 seronegative for human T cell lymphotropic virus type III or lymphadenopathy virus (HTLV-III/LAV) antibody, which showed that repeated exposure by anal intercourse does not necessarily lead to seroconversion. Seropositivity to HTLV-III/LAV was not associated with the absolute number of sexual partners, receptive anal intercourse, or the use of recreational drugs, but was associated with a history of other sexually transmitted diseases (STDs), particularly in the year preceding the patient's initial examination. Acquisition of an STD after the date of last sexual contact with a person with AIDS was strongly associated (p less than 0.001) with the development of persistent generalised lymphadenopathy (PGL). Concurrent or recent STDs would seem to be an important cofactor in developing antibody to HTLV-III/LAV and in the progression of infection from a person being asymptomatic to having PGL.

UI MeSH Term Description Entries
D008297 Male Males
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D006716 Homosexuality The sexual attraction or relationship between members of the same SEX. Homosexuality, Ego-Dystonic,Ego-Dystonic Homosexuality,Homosexuality, Ego Dystonic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000163 Acquired Immunodeficiency Syndrome An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993. AIDS,Immunodeficiency Syndrome, Acquired,Immunologic Deficiency Syndrome, Acquired,Acquired Immune Deficiency Syndrome,Acquired Immuno-Deficiency Syndrome,Acquired Immuno Deficiency Syndrome,Acquired Immuno-Deficiency Syndromes,Acquired Immunodeficiency Syndromes,Immuno-Deficiency Syndrome, Acquired,Immuno-Deficiency Syndromes, Acquired,Immunodeficiency Syndromes, Acquired,Syndrome, Acquired Immuno-Deficiency,Syndrome, Acquired Immunodeficiency,Syndromes, Acquired Immuno-Deficiency,Syndromes, Acquired Immunodeficiency
D012306 Risk The probability that an event will occur. It encompasses a variety of measures of the probability of a generally unfavorable outcome. Relative Risk,Relative Risks,Risk, Relative,Risks,Risks, Relative
D017977 Deltaretrovirus A genus in the family RETROVIRIDAE consisting of exogenous horizontally-transmitted viruses found in a few groups of mammals. Infections caused by these viruses include human B- or adult T-cell leukemia/lymphoma (LEUKEMIA-LYMPHOMA, T-CELL, ACUTE, HTLV-I-ASSOCIATED), and bovine leukemia (ENZOOTIC BOVINE LEUKOSIS). The type species is LEUKEMIA VIRUS, BOVINE. BLV-HTLV Viruses,HTLV Viruses,HTLV-BLV Viruses,Human T-Cell Leukemia Viruses,Human T-Cell Leukemia-Lymphoma Viruses,Leukemia Viruses, Human T-Cell,T-Cell Leukemia Viruses, Human,Human T Cell Leukemia Lymphoma Viruses,Human T Cell Leukemia Viruses,Leukemia Viruses, Human T Cell,T Cell Leukemia Viruses, Human,BLV HTLV Viruses,HTLV BLV Viruses

Related Publications

J N Weber, and A McCreaner, and E Berrie, and J Wadsworth, and D J Jeffries, and A J Pinching, and J R Harris
In vitro infection of human monocytes with human T lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV).
July 1986, Journal of immunology (Baltimore, Md. : 1950),
J N Weber, and A McCreaner, and E Berrie, and J Wadsworth, and D J Jeffries, and A J Pinching, and J R Harris
Transmission of lymphadenopathy-associated virus/human T lymphotropic virus type III in sexual partners. Seropositivity does not predict infectivity in all cases.
July 1986, The American journal of medicine,
J N Weber, and A McCreaner, and E Berrie, and J Wadsworth, and D J Jeffries, and A J Pinching, and J R Harris
Variation among the human T-cell lymphotropic virus type III (HTLV-III/LAV) strains.
March 1987, Journal of theoretical biology,
J N Weber, and A McCreaner, and E Berrie, and J Wadsworth, and D J Jeffries, and A J Pinching, and J R Harris
Evaluation of a new confirmatory assay for antibodies against lymphadenopathy-associated virus (LAV)/human T-lymphotropic virus type III (HTLV III).
January 1986, Vox sanguinis,
J N Weber, and A McCreaner, and E Berrie, and J Wadsworth, and D J Jeffries, and A J Pinching, and J R Harris
Introduction of lymphadenopathy associated virus or human T lymphotropic virus (LAV/HTLV-III) into the male homosexual community in Amsterdam.
February 1986, Genitourinary medicine,
J N Weber, and A McCreaner, and E Berrie, and J Wadsworth, and D J Jeffries, and A J Pinching, and J R Harris
[Prevalence of antibodies against the lymphadenopathy-associated virus/human T-cell lymphotropic virus type III (LAV/HTLV) in a population of homosexuals in Mexico].
January 1986, Salud publica de Mexico,
J N Weber, and A McCreaner, and E Berrie, and J Wadsworth, and D J Jeffries, and A J Pinching, and J R Harris
Serological differences between human T-lymphotropic virus type-I (HTLV-I) and HTLV-III/LAV.
January 1986, Microbiology and immunology,
J N Weber, and A McCreaner, and E Berrie, and J Wadsworth, and D J Jeffries, and A J Pinching, and J R Harris
Human T-lymphotropic virus type III (HTLV-III).
January 1987, Hematologic pathology,
J N Weber, and A McCreaner, and E Berrie, and J Wadsworth, and D J Jeffries, and A J Pinching, and J R Harris
Antigens of human T-lymphotropic virus type III/lymphadenopathy-associated virus.
November 1985, Annals of internal medicine,
J N Weber, and A McCreaner, and E Berrie, and J Wadsworth, and D J Jeffries, and A J Pinching, and J R Harris
Evidence against transmission of human T-lymphotropic virus/lymphadenopathy-associated virus (HTLV-III/LAV) in families of children with the acquired immunodeficiency syndrome.
January 1985, Pediatric infectious disease,
Copied contents to your clipboard!